The safest blood transfusion is the one not administered. When a transfusion is needed, it is
important for both physicians and nursing staff to be aware of its potential acute and delayed …

Many previously widely accepted neonatal transfusion practices are changing as
neonatologists become more aware of the risks to their patients of multiple blood product …

There are many potential noninfectious complications that may be associated with the
transfusion of blood products to the neonate. Most of these can be avoided by the careful …

High risk infants, especially preterm ones, often require the administration of blood products.
Specific guidelines and recommendations on this topic are continually issued and updated …

Background: Transfusions to neonates convey both benefits and risks, and evidence is
needed to guide wise use. Such evidence is accumulating, but more information is needed …

Based on small studies and not on statistically valid clinical trials, guidelines for neonatal
transfusions remain controversial and practices vary greatly. Premature infants and critically …

Red blood cell and blood product transfusion in the fetus, neonate, and premature infant are
often administered with poorly defined indications and unintentional adverse consequences …

Transfusion of red blood cells (RBCs), platelets and fresh frozen plasma (FFP) in neonatal
patients has not been well characterized in the literature, with guidelines varying greatly …

As with many other effective therapies, there are untowned side effects associated with
blood transfusions in newborn infants. Discussed in this article are infectious agents …

Like many treatments available to small or ill neonates, erythrocyte transfusions carry both
benefits and risks. This review examines recent publications aimed at better defining those …